Skip to main content

Clinical Trials Using Hyperpolarized Carbon C 13 Pyruvate

Review the clinical trials studying hyperpolarized carbon c 13 pyruvate on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-25 of 26

Lenvatinib and Pembrolizumab for the Treatment of Locally Advanced or Unresectable Well Differentiated G3 Neuroendocrine Tumors
Status: Active
Location: University of California San Francisco, San Francisco, California
An Investigational Scan (HP 13C MRI) for Assessing Response to Treatment with Abiraterone Acetate and Prednisone prior to Surgery in Patients with High-Risk Prostate Cancer
Status: Active
Location: University of California San Francisco, San Francisco, California
An Investigational Scan (Hyperpolarized 13C Pyruvate MRI) for the Imaging of Cancers
Status: Active
Location: University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland
Serial MR Imaging and MR Spectroscopic Imaging for the Characterization of Lower Grade Glioma
Status: Active
Location: 4 locations
Hyperpolarized 13C Pyruvate With or Without Hyperpolarized 13C, 15N Urea MRI Scan in Predicting Tumor Aggressiveness in Patients with Localized Renal Tumor
Status: Active
Location: 3 locations
Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients with Prostate Cancer on Active Surveillance
Status: Active
Location: 2 locations
Magnetic Resonance Spectroscopic Imaging with Hyperpolarized Carbon C 13 Pyruvate in Finding High-Grade Localized Prostate Cancer in Patients Undergoing Radical Prostatectomy or Who Have Undergone High Intensity Focused Ultrasound Focal Therapy
Status: Active
Location: 2 locations
Hyperpolarized Imaging in Diagnosing Patients with Glioma
Status: Active
Location: 2 locations
Studying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-hydroxyglutarate (2-HG) Using MR Spectroscopy
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Hyperpolarized Carbon C 13 Pyruvate MRI in Imaging Patients with Sarcoma, Prostate, Breast, Brain, or Metastatic Cancer
Status: Active
Location: Memorial Sloan Kettering Cancer Center, New York, New York
Magnetic Resonance Imaging with Hyperpolarized Carbon-13 Pyruvate for the Diagnosis and Treatment Response Monitoring in Patients with Locally Advanced or Metastatic Prostate Cancer
Status: Active
Location: University of California San Francisco, San Francisco, California
Hyperpolarized 13C-Pyruvate With or Without Hyperpolarized 13C, 15N-Urea Magnetic Resonance Imaging Scan for the Imaging of Prostate Cancer
Status: Active
Location: University of California San Francisco, San Francisco, California
Metabolic Magnetic Resonance Imaging for Monitoring Aggressiveness and Response to Therapy in Patients with Advanced Solid Tumors
Status: Active
Location: University of California San Francisco, San Francisco, California
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients with Brain Tumors
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
A Study of [13C]Pyruvate as an Imaging Agent for Magnetic Resonance Imaging in Healthy Volunteers
Status: Active
Location: Memorial Sloan Kettering Cancer Center, New York, New York
An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients with Thyroid Cancer and Other Head and Neck Cancers Undergoing Radiation Therapy and/or Systemic Therapy
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Hyperpolarized Carbon C 13 Pyruvate MRI for the Diagnosis of Patients with Primary Central Nervous System Lymphoma
Status: Active
Location: University of California San Francisco, San Francisco, California
Hyperpolarized Carbon 13 Pyruvate with Magnetic Resonance Spectroscopic Imaging for Characterization of Aggressive Tumor Behavior in Patients with Meningioma
Status: Active
Location: University of California San Francisco, San Francisco, California
Hyperpolarized 13C-Pyruvate Metabolic Magnetic Resonance Imaging for the Diagnosis and Risk-Stratification of Prostate Cancer
Status: Enrolling by Invitation
Location: University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland
Hyperpolarized Carbon 13-Based MRI for the Detection of Radiation-Induced Cardiotoxicity in Patients Receiving Thoracic Radiation
Status: Temporarily Closed to Accrual
Location: UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas
Hyperpolarized Carbon C13 Pyruvate with Magnetic Resonance Spectroscopy for the Detection of Ovarian Cancer and Assessment of Aggressiveness
Status: Temporarily Closed to Accrual
Location: M D Anderson Cancer Center, Houston, Texas
13C-Pyruvate Magnetic Resonance Spectroscopic Imaging in Patients with Pancreatic Cysts Undergoing Surgical Resection
Status: Temporarily Closed to Accrual and Intervention
Location: See ClinicalTrials.gov
Effect of Chemotherapy on the Metabolism of [1-13C] Pyruvate in Cardiac Mitochondria in Patients with Breast Cancer
Status: Active
Location: UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas
Investigational Scan (HP MRI) and Blood-Based Testing for the Early Detection of Pancreatic Adenocarcinoma in Patients with High-Risk Pancreatic Cysts
Status: Active
Location: 7 locations
An Investigational Scan (Hyperpolarized Carbon-13 Pyruvate MRI) for Assessing Treatment Response in Patients with Locally Advanced or Metastatic Pancreatic Ductal Carcinoma
Status: Active
Location: University of California San Francisco, San Francisco, California